Beverly Ann Wynne

Title: The Innovative Contributions of Beverly Ann Wynne

Introduction

Beverly Ann Wynne is a notable inventor based in Worthington, Ohio. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for inhalation therapies. Her work focuses on the delivery of delta-9-tetrahydrocannabinol, a compound with therapeutic potential.

Latest Patents

Wynne holds a patent for a composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent. This stable composition is designed for rapid delivery by inhalation to the lungs and subsequently to the bloodstream. The formulation includes a therapeutically effective amount of delta-9-tetrahydrocannabinol in a pharmaceutically acceptable semiaqueous solvent, which consists of an alcohol, water, and a glycol. The patent specifies volumetric ratios of ethanol, water, and propylene glycol, ensuring a combined total of 100. Additionally, it provides for a sterile and/or preserved sealed unit or multi-unit dosage form of delta-9-tetrahydrocannabinol.

Career Highlights

Wynne is associated with Unimed Pharmaceuticals, Inc., where she has been instrumental in advancing inhalation therapies. Her innovative approach has positioned her as a key figure in the pharmaceutical industry, particularly in the realm of cannabinoid research.

Collaborations

Wynne has collaborated with notable colleagues, including Andrea M McPhillips and Julia J Economou. These partnerships have contributed to the development and refinement of her patented compositions.

Conclusion

Beverly Ann Wynne's contributions to inhalation therapies highlight her innovative spirit and dedication to advancing pharmaceutical science. Her work continues to impact the field positively, paving the way for new therapeutic options.